ER+/HER2+ Metastatic Breast Cancer
2 Tampilan
• 07/03/23
0
0
Menanamkan
administrator
Pelanggan
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru